OCLN and colitis: The loss of ZO-1 and occludin was partially prevented by PGA at 30 mg/kg dose (37.4 ± 2.507 FI%, p <0.0001 for ZO-1 and 33.97 ± 2.217 FI%, p < 0.0001 for occludin; Figure 2A–C), whereas a marked restoration was observed in colitis mice treated with 100 mg/kg PGA in comparison to the DNBS group (87.8 ± 2.579 FI% and 94.75 ± 3.988 FI%, p < 0.0001 for ZO-1 and occludin, respectively; Figure 2A–C).